Diagnostic Validity of a Serological Test with the Current Infection Marker in Thai Adults before and after Eradication Therapy.

infection poses significant health risks, such as gastric adenocarcinoma, necessitating accurate diagnosis and effective treatment in primary care. This study evaluated the diagnostic efficacy of the serological current infection marker (CIM) test in identifying current infection. The CIM test samples from 159 participants undergoing gastroscopy were collected, and -positive outpatients received triple therapy based on histology or rapid urease test results.

No distinction in the gut microbiota between diarrhea predominant-irritable bowel syndrome and healthy subjects: matched case-control study in Thailand.

Background: Alteration in the gut microbiota has been proposed in irritable bowel syndrome (IBS) pathogenesis, especially in the diarrheal type (IBS-D). We conducted this study to evaluate the fecal microbiota in Thai IBS-D patients when compared with healthy subjects as well as to evaluate the effects of probiotics on changes in the gut microbiota correlated with symptoms.

Methods: A matched case-control study was conducted on diagnosed IBS-D patients, based on the Rome IV criteria and healthy controls.